Clinical and Demographic Characteristics of 626 Patients with Moderate and Severe Psoriasis

被引:4
|
作者
Rifaioglu, Emine Nur [1 ]
Ozarmagan, Guzin [2 ]
机构
[1] Mustafa Kemal Univ Tayfur Ata Sokmen, Tip Fak, Dermatol Anabilim Dali, TR-31000 Antakya, Hatay, Turkey
[2] Istanbul Univ, Istanbul Tip Fak, Dermatol Anabilim Dali, Istanbul, Turkey
关键词
Psoriasis; Sociodemography; Clinical Features;
D O I
10.4328/JCAM.2413
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: In our study, we aim to investigate the demographic, clinic features and the treatments of patients with moderate to severe psoriasis who were followed in outpatient clinic of psoriasis of Department of Dermatology in Istanbul Medical School of Istanbul University. Material and Method: One thousand eight hundred and thirty-one patients, who were followed between 2002-2008 in outpatient clinic of psoriasis. were screened and 626 (34%) of them, who were moderate and severe. were evaluated retrospectively. Results: Three hundred five of the patients who participated in our study were female and 321 were male. Mean age of onset was 28.1. Most frequently clinical type was plaque psoriasis. Most frequently nail involvement was pitting in patients. Nail involvement was statistically common in arthropathic patients. Family history was statistically common in psoriasis patients with early onset Retinoid was the most common used systemic drug. Narrow band UVB was the most common used phototherapy. Discussion: Moderate to severe psoriasis rate was 34%. Female to male ratio was close to one another. Peak age of onset of psoriasis was between 16-25 years old. The most common concomitant systemic disease was diabetes mellitus. The findings were consistent with the literature. Consequently psoriasis is a chronic. recurrent, inflammatory dermatologic disease which affect 2% of the word and which negatively affect the quality of life in patients with comorbidities. Especially in severe forms of psoriasis can cause loss of labor in patients. A good knowledge of demographic and clinical characteristics of psoriasis is important to shedding light on the further clinical studies.
引用
收藏
页码:9 / 14
页数:6
相关论文
共 50 条
  • [21] Management of Moderate to Severe Psoriasis in Routine Clinical Practice in Spanish Hospitals
    Lopez-Estebaranz, J. L.
    de la Cueva-Dobao, P.
    de la Torre Fraga, C.
    Galan Gutierrez, M.
    Gonzalez Guerra, E.
    Mollet Sanchez, J.
    Belinchon Romero, I.
    ACTAS DERMO-SIFILIOGRAFICAS, 2018, 109 (07): : 631 - 642
  • [22] Ixekizumab treatment in patients with moderate-to-severe plaque psoriasis in a real-world clinical setting
    Ogut, Neslihan Demirel
    Yildirim, Sema Koc
    Erbagci, Ece
    Hapa, Fatma Asli
    JOURNAL OF COSMETIC DERMATOLOGY, 2022, 21 (11) : 6215 - 6224
  • [23] Patients with moderate-to-severe psoriasis recapture clinical response during re-treatment with etanercept
    Ortonne, J. -P.
    Taieb, A.
    Ormerod, A. D.
    Robertson, D.
    Foehl, J.
    Pedersen, R.
    Molta, C.
    Freundlich, B.
    BRITISH JOURNAL OF DERMATOLOGY, 2009, 161 (05) : 1190 - 1195
  • [24] Risankizumab for the treatment of moderate to severe psoriasis
    Chiricozzi, Andrea
    Antonioli, Luca
    Panduri, Salvatore
    Fornai, Matteo
    Romanelli, Marco
    Blandizzi, Corrado
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (01) : 1 - 8
  • [25] Treatment Approaches to Moderate to Severe Psoriasis
    Gisondi, Paolo
    Del Giglio, Micol
    Girolomoni, Giampiero
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (11):
  • [26] Clinical, dermoscopic, and ultrasonic monitoring of the response to biologic treatment in patients with moderate-to-severe plaque psoriasis
    Wang, Juncheng
    Zhu, Qingli
    Li, Feng
    Xiao, Mengsu
    Liu, Jie
    FRONTIERS IN MEDICINE, 2023, 10
  • [27] Mild Cognitive Impairment in Patients with Moderate to Severe Chronic Plaque Psoriasis
    Gisondi, Paolo
    Sala, Francesca
    Alessandrini, Franco
    Avesani, Virginia
    Zoccatelli, Giada
    Beltramello, Alberto
    Moretto, Giuseppe
    Gambina, Giuseppe
    Girolomoni, Giampiero
    DERMATOLOGY, 2014, 228 (01) : 78 - 85
  • [28] Biologicals for moderate-to-severe plaque type psoriasis in pediatric patients
    Libon, Florence
    Lebas, Eve
    De Schaetzen, Virginie
    Sabatiello, Murielle
    De Schepper, Sofie
    Nikkels, Arjen F.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (09) : 947 - 955
  • [29] Underdiagnosis and undertreatment of cardiovascular risk factors in patients with moderate to severe psoriasis
    Kimball, Alexa B.
    Szapary, Philippe
    Mrowietz, Ulrich
    Reich, Kristian
    Langley, Richard G.
    You, Yin
    Hsu, Ming-Chun
    Yeilding, Newman
    Rader, Daniel J.
    Mehta, Nehal N.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 67 (01) : 76 - 85
  • [30] Economic and Comorbidity Burden Among Patients with Moderate-to-Severe Psoriasis
    Feldman, Steven R.
    Zhao, Yang
    Shi, Lizheng
    Tran, Mary Helen
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2015, 21 (10) : 874 - 888